SCHEMBL1980146

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL1979175	0.89	AR (0.44)	ARSMN1; SMN2MEN1LMNATP53
	SCHEMBL30939559	0.88	ELANE (0.34)	ARKMT2AALDH1A1ESRRBESR1
	SCHEMBL13720756	0.88	ELANE (0.34)	ARKMT2AALDH1A1ESRRBESR1
	SCHEMBL18952946	0.88	AR (0.36)	ARESRRBESR1ESRRAESRRG
	SCHEMBL21610138	0.84	AR (0.39)	ARSMN1; SMN2KDM4EALDH1A1HPGD
	SCHEMBL1980895	0.82	AR (0.46)	ARSMN1; SMN2MEN1LMNATP53
	SCHEMBL1980831	0.81	AR (0.53)	ARSMN1; SMN2MEN1LMNATP53
	SCHEMBL17554782	0.79	KMT2A (0.33)	KMT2AESRRBESR1ESRRAESRRG
	SCHEMBL18952970	0.79	AR (0.36)	ARESRRBESR1ESRRAESRRG
	SCHEMBL1979370	0.78	ELANE (0.35)	ARPGRESRRBESR1ESRRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.